Trial Profile
Ascending multiple dose study of the safety, tolerability, and pharmacokinetics of methylnaltrexone bromide (MOA-728) administered orally to healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation
- Focus Pharmacokinetics
- Sponsors Bausch Health Companies; Wyeth
- 27 Jul 2011 New trial record